Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Dietrich Beelen

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Disorders

Concepts & Ideas

Phenomena

Recurrence

Living Beings

Chemicals & Drugs

bcr-abl Fusion Proteins

Physiology

Hematopoiesis

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
56
Schaefer, Ulrich
45
Elmaagacli, Ahmet
25
Grosse-Wilde, Hans
24
Trenschel, Rudolf
24
Ottinger, Hellmut
22
Koldehoff, Michael
17
Kvasnicka, Hans Michael
17
Steckel, Nina
17
Kvasnicka, Hans Michael
15
Peceny, Rudolf
13
Ditschkowski, Markus
12
Schaefer, Ullrich Wilhelm
10
Wickenhauser, Claudia
10
Opalka, Bertram
9
Varus, Eva

Sign-in to see all Coauthors

Publications

TOP 3
Bacher Ulrike; Klyuchnikov Evgeny; Zabelina Tatjana; Ottinger Hellmut; Beelen Dietrich W; Schrezenmeier Hubert; Ehninger Gerhard; Müller Carlheinz; Berger Jürgen; Suttorp Meinolf; Kolb Hans-Jochem; Kröger Nicolaus; Zander Axel R
The changing scene of allogeneic stem cell transplantation for chronic myeloid leukemia--a report from the German Registry covering the period from 1998 to 2004.
Elmaagacli A H; Koldehoff M; Beelen D W
Improved outcome of hematopoietic SCT in patients with homozygous gene variant of Toll-like receptor 9.
Kröger Nicolaus; Brand Ronald; van Biezen Anja; Zander Axel; Dierlamm Judith; Niederwieser Dietger; Devergie Agnès; Ruutu Tapani; Cornish Jackie; Ljungman Per; Gratwohl Alois; Cordonnier Catherine; Beelen Dietrich; Deconinck Eric; Symeonidis Argiris; de Witte Theo;
Risk factors for therapy-related myelodysplastic syndrome and acute myeloid leukemia treated with allogeneic stem cell transplantation.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Dietrich Beelen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Bacher Ulrike; Klyuchnikov Evgeny; Zabelina Tatjana; Ottinger Hellmut; Beelen Dietrich W; Schrezenmeier Hubert; Ehninger Gerhard; Müller Carlheinz; Berger Jürgen; Suttorp Meinolf; Kolb Hans-Jochem; Kröger Nicolaus; Zander Axel R
The changing scene of allogeneic stem cell transplantation for chronic myeloid leukemia--a report from the German Registry covering the period from 1998 to 2004.
Annals of hematology 2009;88(12):1237-47.
2009: Elmaagacli A H; Koldehoff M; Beelen D W
Improved outcome of hematopoietic SCT in patients with homozygous gene variant of Toll-like receptor 9.
Bone marrow transplantation 2009;44(5):295-302.
2009: Kröger Nicolaus; Brand Ronald; van Biezen Anja; Zander Axel; Dierlamm Judith; Niederwieser Dietger; Devergie Agnès; Ruutu Tapani; Cornish Jackie; Ljungman Per; Gratwohl Alois; Cordonnier Catherine; Beelen Dietrich; Deconinck Eric; Symeonidis Argiris; de Witte Theo;
Risk factors for therapy-related myelodysplastic syndrome and acute myeloid leukemia treated with allogeneic stem cell transplantation.
Haematologica 2009;94(4):542-9.
2009: Braess Jan; Spiekermann Karsten; Staib Peter; Grüneisen Andreas; Wörmann Bernhard; Ludwig Wolf-Dieter; Serve Hubert; Reichle Albrecht; Peceny Rudolf; Oruzio Daniel; Schmid Christoph; Schiel Xaver; Hentrich Marcus; Sauerland Christina; Unterhalt Michael; Fiegl Michael; Kern Wolfgang; Buske Christian; Bohlander Stefan; Heinecke Achim; Baurmann Herrad; Beelen Dietrich W; Berdel Wolfgang E; Büchner Thomas; Hiddemann Wolfgang
Dose-dense induction with sequential high-dose cytarabine and mitoxantone (S-HAM) and pegfilgrastim results in a high efficacy and a short duration of critical neutropenia in de novo acute myeloid leukemia: a pilot study of the AMLCG.
Blood 2009;113(17):3903-10.
2008: Kordelas Lambros; Trenschel Rudolf; Koldehoff Michael; Elmaagacli Ahmet; Beelen Dietrich W
Successful treatment of EBV PTLD with CNS lymphomas with the monoclonal anti-CD20 antibody rituximab.
Onkologie 2008;31(12):691-3.
2008: Koldehoff Michael; Beelen Dietrich W; Elmaagacli Ahmet H
Small-molecule inhibition of proteasome and silencing by vascular endothelial cell growth factor-specific siRNA induce additive antitumor activity in multiple myeloma.
Journal of leukocyte biology 2008;84(2):561-76.
2008: Fouillard Loic; Labopin Myriam; Gratwohl Alois; Gluckman Eliane; Frassoni Francesco; Beelen Dietrich W; Willemze Roelof; Montserrat Emili; Blaise Didier; Atienza Arturo Iriondo; Sierra Jorge; Santos Moema; Gorin Norbert-Claude; Rocha Vanderson;
Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission.
Haematologica 2008;93(6):834-41.
2008: Elmaagacli A H; Koldehoff M; Landt O; Beelen D W
Relation of an interleukin-23 receptor gene polymorphism to graft-versus-host disease after hematopoietic-cell transplantation.
Bone marrow transplantation 2008;41(9):821-6.
2008: Koldehoff Michael; Zakrzewski Johannes L; Klein-Hitpass Ludger; Beelen Dietrich W; Elmaagacli Ahmet H
Gene profiling of growth factor independence 1B gene (Gfi-1B) in leukemic cells.
International journal of hematology 2008;87(1):39-47.
2008: Siebolts Udo; Thiele Jürgen; Zander Thomas; Ditschkowski Markus; Beelen Dietrich W; Kröger Nicolaus; Fehse Boris; Wickenhauser Claudia
Differences in proportion and dynamics of recipient hematopoiesis following hematopoietic cell transplantation in CML and IMF.
Oncology reports 2008;19(1):287-92.
2008: Bethge Wolfgang A; Faul Christoph; Bornhäuser Martin; Stuhler Gernot; Beelen Dietrich W; Lang Peter; Stelljes Matthias; Vogel Wichard; Hägele Matthias; Handgretinger Rupert; Kanz Lothar
Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: an update.
Blood cells, molecules & diseases 2008;40(1):13-9.
2007: Elmaagacli A H; Koldehoff M; Steckel N K; Trenschel R; Ottinger H; Beelen D W
Cytochrome P450 2C19 loss-of-function polymorphism is associated with an increased treatment-related mortality in patients undergoing allogeneic transplantation.
Bone marrow transplantation 2007;40(7):659-64.
2007: Koldehoff M; Steckel N K; Beelen D W; Elmaagacli A H
Therapeutic application of small interfering RNA directed against bcr-abl transcripts to a patient with imatinib-resistant chronic myeloid leukaemia.
Clinical and experimental medicine 2007;7(2):47-55.
2007: Steckel Nina K; Koldehoff Michael; Ditschkowski Markus; Beelen Dietrich W; Elmaagacli Ahmet H
Use of the activating gene mutation of the tyrosine kinase (VAL617Phe) JAK2 as a minimal residual disease marker in patients with myelofibrosis and myeloid metaplasia after allogeneic stem cell transplantation.
Transplantation 2007;83(11):1518-20.
2007: Ditschkowski Markus; Elmaagacli Ahmet H; Trenschel Rudolf; Peceny Rudolf; Koldehoff Michael; Schulte Claudia; Beelen Dietrich W
T-cell depletion prevents from bronchiolitis obliterans and bronchiolitis obliterans with organizing pneumonia after allogeneic hematopoietic stem cell transplantation with related donors.
Haematologica 2007;92(4):558-61.
2007: Schmidt-Hieber M; Blau I W; Trenschel R; Andreesen R; Stuhler G; Einsele H; Kanz L; Keilholz U; Marinets O; Beelen D W; Fauser A A; Volin L; Ruutu T; Uharek L; Fietz T; Knauf W; Hopfenmüller W; Thiel E; Freund M; Casper J
Reduced-toxicity conditioning with fludarabine and treosulfan prior to allogeneic stem cell transplantation in multiple myeloma.
Bone marrow transplantation 2007;39(7):389-96.
2007: Thiele J; Varus E; Siebolts U; Kvasnicka H M; Wickenhauser C; Metz K A; Beelen D W; Ditschkowski M; Zander A; Kröger N
Dualism of mixed chimerism between hematopoiesis and stroma in chronic idiopathic myelofibrosis after allogeneic stem cell transplantation.
Histology and histopathology 2007;22(4):365-72.
2007: Fischer Johannes C; Ottinger Hellmut; Ferencik Stanislav; Sribar Martina; Punzel Michael; Beelen Dietrich W; Schwan M Alexander; Grosse-Wilde Hans; Wernet Peter; Uhrberg Markus
Relevance of C1 and C2 epitopes for hemopoietic stem cell transplantation: role for sequential acquisition of HLA-C-specific inhibitory killer Ig-like receptor.
Journal of immunology (Baltimore, Md. : 1950) 2007;178(6):3918-23.
2007: Elmaagacli Ahmet H; Koldehoff Michael; Zakrzewski Johannes L; Steckel Nina K; Ottinger Hellmut; Beelen Dietrich W
Growth factor-independent 1B gene (GFI1B) is overexpressed in erythropoietic and megakaryocytic malignancies and increases their proliferation rate.
British journal of haematology 2007;136(2):212-9.
2006: Ditschkowski Markus; Elmaagacli Ahmet H; Trenschel Rudolf; Steckel Nina K; Koldehoff Michael; Beelen Dietrich W
No influence of V617F mutation in JAK2 on outcome after allogeneic hematopoietic stem cell transplantation (HSCT) for myelofibrosis.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(12):1350-1.
2006: Lindemann Monika; Ottinger Hellmut D; Elmaagacli Ahmet H; Trenschel Rudolf; Rebmann Vera; Beelen Dietrich W; Grosse-Wilde Hans
Donor cell reaction to OKT3 as predictor of chronic graft-vs-host disease in hematopoietic stem cell recipients.
Experimental hematology 2006;34(12):1753-8.
2006: Koldehoff Michael; Steckel Nina K; Hlinka Michal; Beelen Dietrich W; Elmaagacli Ahmet H
Quantitative analysis of chimerism after allogeneic stem cell transplantation by real-time polymerase chain reaction with single nucleotide polymorphisms, standard tandem repeats, and Y-chromosome-specific sequences.
American journal of hematology 2006;81(10):735-46.
2006: Wassmann Barbara; Pfeifer Heike; Goekbuget Nicola; Beelen Dietrich W; Beck Joachim; Stelljes Matthias; Bornhäuser Martin; Reichle Albrecht; Perz Jolanta; Haas Rainer; Ganser Arnold; Schmid Mathias; Kanz Lothar; Lenz Georg; Kaufmann Martin; Binckebanck Anja; Brück Patrick; Reutzel Regina; Gschaidmeier Harald; Schwartz Stefan; Hoelzer Dieter; Ottmann Oliver G
Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL).
Blood 2006;108(5):1469-77.
2006: Koldehoff M; Steckel N K; Beelen D W; Elmaagacli A H
Synthetic small interfering RNAs reduce bcr-abl gene expression in leukaemic cells of de novo Philadelphia(+) acute myeloid leukaemia.
Clinical and experimental medicine 2006;6(1):45-7.
2006: Ditschkowski M; Elmaagacli A H; Trenschel R; Steckel N K; Koldehoff M; Beelen D W
Myeloablative allogeneic hematopoietic stem cell transplantation in elderly patients.
Clinical transplantation 2006;20(1):127-31.
2006: Elmaagacli Ahmet H; Koldehoff Michael; Hindahl Heidrun; Steckel Nina K; Trenschel Rudolf; Peceny Rudolf; Ottinger Hellmut; Rath Peter-Michael; Ross Rudolf Stefan; Roggendorf Michael; Grosse-Wilde Hans; Beelen Dietrich W
Mutations in innate immune system NOD2/CARD 15 and TLR-4 (Thr399Ile) genes influence the risk for severe acute graft-versus-host disease in patients who underwent an allogeneic transplantation.
Transplantation 2006;81(2):247-54.
2005: Widmann Thomas Alexander; Willmann Barbara; Pfreundschuh Michael; Beelen Dietrich W
Influence of telomere length on short-term recovery after allogeneic stem cell transplantation.
Experimental hematology 2005;33(10):1257-61.
2005: Koldehoff M; Elmaagacli A H; Steckel N K; Trenschel R; Hlinka M; Ditschkowski M; Beelen D W
Successful treatment of patients with respiratory failure due to fungal infection after allogeneic hematopoietic stem cell transplantation.
Transplant infectious disease : an official journal of the Transplantation Society 2005;7(3-4):137-45.
2005: Thiele J; Kvasnicka H M; Dietrich H; Stein G; Hann M; Kaminski A; Rathjen N; Metz K A; Beelen D W; Ditschkowski M; Zander A; Kroeger N
Dynamics of bone marrow changes in patients with chronic idiopathic myelofibrosis following allogeneic stem cell transplantation.
Histology and histopathology 2005;20(3):879-89.
2005: Schulte Claudia M S; Beelen Dietrich W
Low pretransplant bone-mineral density and rapid bone loss do not increase risk for avascular osteonecrosis after allogeneic hematopoietic stem cell transplantation.
Transplantation 2005;79(12):1748-55.
2005: Elmaagacli Ahmet H; Ottinger Hellmut; Koldehoff Michael; Peceny Rudolf; Steckel Nina K; Trenschel Rudolf; Biersack Harald; Grosse-Wilde Hans; Beelen Dietrich W
Reduced risk for molecular disease in patients with chronic myeloid leukemia after transplantation from a KIR-mismatched donor.
Transplantation 2005;79(12):1741-7.
2005: Trenschel R; Ditschkowski M; Elmaagacli A H; Koldehoff M; Ottinger H; Steckel N; Hlinka M; Peceny R; Rath P-M; Dermoumi H; Beelen D W
Caspofungin as second-line therapy for fever of unknown origin or invasive fungal infection following allogeneic stem cell transplantation.
Bone marrow transplantation 2005;35(6):583-6.
2005: Elmaagacli Ahmet H; Koldehoff Michael; Peceny Rudolf; Klein-Hitpass Ludger; Ottinger Helmut; Beelen Dietrich W; Opalka Bertram
WT1 and BCR-ABL specific small interfering RNA have additive effects in the induction of apoptosis in leukemic cells.
Haematologica 2005;90(3):326-34.
2005: Beelen Dietrich W; Ottinger Hellmut D; Ferencik Stanislav; Elmaagacli Ahmet H; Peceny Rudolf; Trenschel Rudolf; Grosse-Wilde Hans
Genotypic inhibitory killer immunoglobulin-like receptor ligand incompatibility enhances the long-term antileukemic effect of unmodified allogeneic hematopoietic stem cell transplantation in patients with myeloid leukemias.
Blood 2005;105(6):2594-600.
2005: Lindemann Monika; Grosse-Wilde Hans; Ottinger Hellmut D; Peceny Rudolf; Beelen Dietrich W
G-CSF-induced alteration of in vitro alloreactivity in stem cell donors is predictive for the occurrence of acute GVHD in recipients.
Transplantation 2005;79(3):377-8.
2005: Steckel N K; Koldehoff M; Beelen D W; Elmaagacli A H
Indoleamine 2,3-dioxygenase expression in monocytes of healthy nonpregnant women after induction with human choriongonadotropine.
Scandinavian journal of immunology 2005;61(2):213-4.
2005: Beelen D W; Trenschel R; Casper J; Freund M; Hilger R A; Scheulen M E; Basara N; Fauser A A; Hertenstein B; Mylius H A; Baumgart J; Pichlmeier U; Hahn J R; Holler E
Dose-escalated treosulphan in combination with cyclophosphamide as a new preparative regimen for allogeneic haematopoietic stem cell transplantation in patients with an increased risk for regimen-related complications.
Bone marrow transplantation 2005;35(3):233-41.
2005: Remberger Mats; Beelen Dietrich W; Fauser Axel; Basara Nadezda; Basu Oliver; Ringdén Olle
Increased risk of extensive chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation using unrelated donors.
Blood 2005;105(2):548-51.
2004: Koldehoff M; Beelen D W; Trenschel R; Steckel N K; Peceny R; Ditschkowski M; Ottinger H; Elmaagacli A H
Outcome of hematopoietic stem cell transplantation in patients with atypical chronic myeloid leukemia.
Bone marrow transplantation 2004;34(12):1047-50.
2004: Hilger R A; Baumgart J; Scheulen M E; Trenschel R; Strumberg D; Seeber S; Beelen D W
Pharmacokinetics of treosulfan in a myeloablative combination with cyclophosphamide prior to allogeneic hematopoietic stem cell transplantation.
International journal of clinical pharmacology and therapeutics 2004;42(11):654-5.
2004: Kasper Christoph; Lübking Anna; Beelen Dietrich W; Dührsen Ullrich
Interferon alpha (IFN) treatment of bone marrow stroma inhibits haematopoesis.
Leukemia research 2004;28(11):1217-20.
2004: Ditschkowski M; Beelen D W; Trenschel R; Koldehoff M; Elmaagacli A H
Outcome of allogeneic stem cell transplantation in patients with myelofibrosis.
Bone marrow transplantation 2004;34(9):807-13.
2004: Ottinger H D; Ferencik S; Beelen D W; Lindemann M; Peceny R; Elmaagacli A H; Grosse-Wilde H
Impact of HLA-A,B,C allele mismatches on outcome after unrelated blood stem cell transplantation in whites.
Transplantation 2004;78(7):1077-80.
2004: Schulte Claudia M S; Beelen Dietrich W
Avascular osteonecrosis after allogeneic hematopoietic stem-cell transplantation: diagnosis and gender matter.
Transplantation 2004;78(7):1055-63.
2004: Thiele Juergen; Varus Eva; Wickenhauser Claudia; Kvasnicka Hans Michael; Lorenzen Johann; Gramley Felix; Metz Klaus Alfred; Rivero Francisco; Beelen Dietrich Wilhelm
Mixed chimerism of cardiomyocytes and vessels after allogeneic bone marrow and stem-cell transplantation in comparison with cardiac allografts.
Transplantation 2004;77(12):1902-5.
2004: Schulte Claudia M S; Beelen Dietrich W
Bone loss following hematopoietic stem cell transplantation: a long-term follow-up.
Blood 2004;103(10):3635-43.
2004: Heinemann Falko M; Ferencik Stanislav; Ottinger Hellmut D; Beelen Dietrich W; Grosse-Wilde Hans
Impact of disparity of minor histocompatibility antigens HA-1, CD31, and CD49b in hematopoietic stem cell transplantation of patients with chronic myeloid leukemia with sibling and unrelated donors.
Transplantation 2004;77(7):1103-6.
2004: Thiele J; Varus E; Wickenhauser C; Kvasnicka H M; Metz K A; Beelen D W
Regeneration of heart muscle tissue: quantification of chimeric cardiomyocytes and endothelial cells following transplantation.
Histology and histopathology 2004;19(1):201-9.
2003: Ditschkowski M; Trenschel R; Kummer G; Elmaagacli A H; Beelen D W
Allogeneic CD34-enriched peripheral blood stem cell transplantation in a patient with paroxysmal nocturnal haemoglobinuria.
Bone marrow transplantation 2003;32(6):633-5.
2003: Zander A R; Kröger N; Schleuning M; Finke J; Zabelina T; Beelen D; Schwerdtfeger R; Baurmann H; Bornhäuser M; Ehninger G; Fauser A A; Kiehl M; Trenschel R; Ottinger H D; Bertz H; Berger J; Kolb H-J; Schaefer U W
ATG as part of the conditioning regimen reduces transplant-related mortality (TRM) and improves overall survival after unrelated stem cell transplantation in patients with chronic myelogenous leukemia (CML).
Bone marrow transplantation 2003;32(4):355-61.
2003: Ottinger Hellmut D; Ferencik Stanislav; Beelen Dietrich W; Lindemann Monika; Peceny Rudolf; Elmaagacli Ahmed H; Husing Johannes; Grosse-Wilde Hans
Hematopoietic stem cell transplantation: contrasting the outcome of transplantations from HLA-identical siblings, partially HLA-mismatched related donors, and HLA-matched unrelated donors.
Blood 2003;102(3):1131-7.
2003: Ditschkowski Markus; Einsele Hermann; Schwerdtfeger Rainer; Bunjes Donald; Trenschel Rudolf; Beelen Dietrich W; Elmaagacli Ahmet H
Improvement of inflammatory bowel disease after allogeneic stem-cell transplantation.
Transplantation 2003;75(10):1745-7.
2003: Thiele J; Wickenhauser C; Kvasnicka H M; Varus E; Beelen D W; Schaefer U W
Dynamics of lineage-restricted mixed chimerism following sex-mismatched allogeneic bone marrow transplantation.
Histology and histopathology 2003;18(2):557-74.
2003: Kvasnicka Hans M; Wickenhauser Claudia; Thiele Juergen; Varus Eva; Hamm Katharina; Beelen Dietrich W; Schaefer Ullrich W
Mixed chimerism of bone marrow vessels (endothelial cells, myofibroblasts) following allogeneic transplantation for chronic myelogenous leukemia.
Leukemia & lymphoma 2003;44(2):321-8.
2003: Steckel N K; Kuhn U; Beelen D W; Elmaagacli A H
Indoleamine 2,3-dioxygenase expression in patients with acute graft-versus-host disease after allogeneic stem cell transplantation and in pregnant women: association with the induction of allogeneic immune tolerance?
Scandinavian journal of immunology 2003;57(2):185-91.
2003: Ansorg R; Rath P-M; Runde V; Beelen D W
Influence of intestinal decontamination using metronidazole on the detection of methanogenic Archaea in bone marrow transplant recipients.
Bone marrow transplantation 2003;31(2):117-9.
2003: Elmaagacli Ahmet H; Peceny Rudolf; Steckel Nina; Trenschel Rudolf; Ottinger Hellmut; Grosse-Wilde Hans; Schaefer Ulrich W; Beelen Dietrich W
Outcome of transplantation of highly purified peripheral blood CD34+ cells with T-cell add-back compared with unmanipulated bone marrow or peripheral blood stem cells from HLA-identical sibling donors in patients with first chronic phase chronic myeloid leukemia.
Blood 2003;101(2):446-53.
2003: Thiele J; Wickenhauser C; Kvasnicka H M; Varus E; Schneider C; Müller H; Beelen D W
Mixed chimerism of erythro- and megakaryopoiesis following allogeneic bone marrow transplantation.
Acta haematologica 2003;109(4):176-83.
2002: Beelen D W; Ottinger H; Kolbe K; Pönisch W; Sayer H G; Knauf W; Stockschläder M; Scheid C; Schaefer U W
Filgrastim mobilization and collection of allogeneic blood progenitor cells from adult family donors: first interim report of a prospective German multicenter study.
Annals of hematology 2002;81(12):701-9.
2002: Arnold R; Massenkeil G; Bornhäuser M; Ehninger G; Beelen D W; Fauser A A; Hegenbart U; Hertenstein B; Ho A D; Knauf W; Kolb H J; Kolbe K; Sayer H G; Schwerdtfeger R; Wandt H; Hoelzer D
Nonmyeloablative stem cell transplantation in adults with high-risk ALL may be effective in early but not in advanced disease.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2002;16(12):2423-8.
2002: Thiele J; Varus E; Wickenhauser C; Kvasnicka H M; Metz K; Schaefer U W; Beelen D W
[Chimerism of cardiomyocytes and endothelial cells after allogeneic bone marrow transplantation in chronic myeloid leukemia. An autopsy study]
Der Pathologe 2002;23(6):405-10.
2002: Thiele Juergen; Wickenhauser Claudia; Kvasnicka Hans Michael; Varus Eva; Kleppe Stephanie; Beelen Dietrich Wilhelm; Schaefer Ullrich Wilhelm
Mixed chimerism of bone marrow CD34+ progenitor cells (genotyping, bcr/abl analysis) after allogeneic transplantation for chronic myelogenous leukemia.
Transplantation 2002;74(7):982-6.
2002: Thiele Juergen; Kvasnicka Hans Michael; Beelen Dietrich Wilhelm; Cicek Guelken; Leder Lutz-Dietrich; Schaefer Ulrich Wilhelm
Dynamics of CD34+ progenitor cells following allogeneic bone marrow transplantation in Ph1+CML--an immunohistochemical study on 113 patients with sequential trephine biopsies.
Journal of hematotherapy & stem cell research 2002;11(3):565-74.
2002: Ottinger Hellmut D; Rebmann Vera; Pfeiffer Kerstin A; Beelen Dietrich W; Kremens Bernhard; Runde Volker; Schaefer Ulrich W; Grosse-Wilde Hans
Positive serum crossmatch as predictor for graft failure in HLA-mismatched allogeneic blood stem cell transplantation.
Transplantation 2002;73(8):1280-5.
2002: Elmaagacli Ahmet H; Basoglu Semiha; Peceny Rudolf; Trenschel Rudolf; Ottinger Hellmut; Lollert Andre; Runde Volker; Grosse-Wilde Hans; Beelen Dietrich W; Schaefer Ulrich W
Improved disease-free-survival after transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical unrelated donors in patients with first chronic phase chronic myeloid leukemia.
Blood 2002;99(4):1130-5.
2002: Wickenhauser Claudia; Thiele Juergen; Pérez Fernando; Varus Eva; Stoffel Marc Sebastian; Kvasnicka Hans Michael; Beelen Dietrich Wilhelm; Schaefer Ullrich Wilhelm
Mixed chimerism of the resident macrophage population after allogeneic bone marrow transplantation for chronic myeloid leukemia.
Transplantation 2002;73(1):104-11.
2002: Beelen D W; Schaefer U W
Allogeneic stem cell transplants in chronic myeloid leukemia.
Annals of hematology 2002;81 Suppl 2():S45-6.
2001: Remberger M; Ringdén O; Blau I W; Ottinger H; Kremens B; Kiehl M G; Aschan J; Beelen D W; Basara N; Kumlien G; Fauser A A; Runde V
No difference in graft-versus-host disease, relapse, and survival comparing peripheral stem cells to bone marrow using unrelated donors.
Blood 2001;98(6):1739-45.
2001: Elmaagacli A H; Freist A; Hahn M; Opalka B; Seeber S; Schaefer U W; Beelen D W
Estimating the relapse stage in chronic myeloid leukaemia patients after allogeneic stem cell transplantation by the amount of BCR-ABL fusion transcripts detected using a new real-time polymerase chain reaction method.
British journal of haematology 2001;113(4):1072-5.
2001: Elmaagacli A H; Runkel K; Steckel N; Opalka B; Trenschel R; Seeber S; Schaefer U W; Beelen D W
A comparison of chimerism and minimal residual disease between four different allogeneic transplantation methods in patients with chronic myelogenous leukemia in first chronic phase.
Bone marrow transplantation 2001;27(8):809-15.
2001: Thiele J; Kvasnicka H M; Beelen D W; Welter A; Schneider S; Leder L D; Schaefer U W
Reconstitution of the CD45RO(+) and CD20(+) lymphoid marrow population following allogeneic bone marrow transplantation for Ph(+) CML.
Bone marrow transplantation 2001;27(4):425-31.
2001: Thiele J; Kvasnicka H M; Beelen D W; Flucke U; Spoer C; Paperno S; Leder L D; Schaefer U W
Megakaryopoiesis and myelofibrosis in chronic myeloid leukemia after allogeneic bone marrow transplantation: an immunohistochemical study of 127 patients.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2001;14(2):129-38.
2001: Thiele J; Kvasnicka H M; Beelen D W; Leder L D; Schaefer U W
Bone marrow engraftment: histopathology of hematopoietic reconstitution following allogeneic transplantation in CML patients.
Histology and histopathology 2001;16(1):213-26.
2000: Trenschel R; Peceny R; Runde V; Elmaagacli A; Dermoumi H; Heintschel von Heinegg E; Müller K D; Schaefer U W; Beelen D W
Fungal colonization and invasive fungal infections following allogeneic BMT using metronidazole, ciprofloxacin and fluconazole or ciprofloxacin and fluconazole as intestinal decontamination.
Bone marrow transplantation 2000;26(9):993-7.
2000: Beelen D W; Peceny R; Elmaagacli A; Ottinger H; Kummer G; Opalka B; Seeber S; Schaefer U W
Transplantation of highly purified HLA-identical sibling donor peripheral blood CD34+ cells without prophylactic post-transplant immunosuppression in adult patients with first chronic phase chronic myeloid leukemia: results of a phase II study.
Bone marrow transplantation 2000;26(8):823-9.
2000: Thiele J; Kvasnicka H M; Beelen D W; Wenzel P; Koepke M L; Leder L D; Schaefer U W
Macrophages and their subpopulations following allogenic bone marrow transplantation for chronic myeloid leukaemia.
Virchows Archiv : an international journal of pathology 2000;437(2):160-6.
2000: Elmaagacli A H; Beelen D W; Opalka B; Seeber S; Schaefer U W
The amount of BCR-ABL fusion transcripts detected by the real-time quantitative polymerase chain reaction method in patients with Philadelphia chromosome positive chronic myeloid leukemia correlates with the disease stage.
Annals of hematology 2000;79(8):424-31.
2000: Thiele J; Kvasnicka H M; Beelen D W; Zirbes T K; Jung F; Reske D; Leder L D; Schaefer U W
Relevance and dynamics of myelofibrosis regarding hematopoietic reconstitution after allogeneic bone marrow transplantation in chronic myelogenous leukemia--a single center experience on 160 patients.
Bone marrow transplantation 2000;26(3):275-81.
2000: Thiele J; Kvasnicka H M; Beelen D W; Pilgram B; Rose A; Leder L D; Schaefer U W
Erythropoietic reconstitution, macrophages and reticulin fibrosis in bone marrow specimens of CML patients following allogeneic transplantation.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2000;14(8):1378-85.
2000: Ringdén O; Remberger M; Runde V; Bornhäuser M; Blau I W; Basara N; Hölig K; Beelen D W; Hägglund H; Basu O; Ehninger G; Fauser A A
Faster engraftment of neutrophils and platelets with peripheral blood stem cells from unrelated donors: a comparison with marrow transplantation.
Bone marrow transplantation 2000;25 Suppl 2():S6-8.
2000: Elmaagacli A H; Beelen D W; Trenschel R; Schaefer U W
The detection of wt-1 transcripts is not associated with an increased leukemic relapse rate in patients with acute leukemia after allogeneic bone marrow or peripheral blood stem cell transplantation.
Bone marrow transplantation 2000;25(1):91-6.
1999: Ringdén O; Remberger M; Runde V; Bornhäuser M; Blau I W; Basara N; Hölig K; Beelen D W; Hägglund H; Basu O; Ehninger G; Fauser A A
Peripheral blood stem cell transplantation from unrelated donors: a comparison with marrow transplantation.
Blood 1999;94(2):455-64.
1999: Elmaagacli A H; Beelen D W; Opalka B; Seeber S; Schaefer U W
The risk of residual molecular and cytogenetic disease in patients with Philadelphia-chromosome positive first chronic phase chronic myelogenous leukemia is reduced after transplantation of allogeneic peripheral blood stem cells compared with bone marrow.
Blood 1999;94(2):384-9.
1999: Beelen D W; Elmaagacli A; Müller K D; Hirche H; Schaefer U W
Influence of intestinal bacterial decontamination using metronidazole and ciprofloxacin or ciprofloxacin alone on the development of acute graft-versus-host disease after marrow transplantation in patients with hematologic malignancies: final results and long-term follow-up of an open-label prospective randomized trial.
Blood 1999;93(10):3267-75.
1999: Elmaagacli A H; Beelen D W; Trenn G; Schmidt O; Nahler M; Schaefer U W
Induction of a graft-versus-leukemia reaction by cyclosporin A withdrawal as immunotherapy for leukemia relapsing after allogeneic bone marrow transplantation.
Bone marrow transplantation 1999;23(8):771-7.
1998: Elmaagacli A H; Beelen D W; Kroll M; Trzensky S; Stein C; Schaefer U W
Detection of CBFbeta/MYH11 fusion transcripts in patients with inv(16) acute myeloid leukemia after allogeneic bone marrow or peripheral blood progenitor cell transplantation.
Bone marrow transplantation 1998;21(2):159-66.
1997: Elmaagacli A H; Beelen D W; Schaefer U W
A retrospective single centre study of the outcome of five different therapy approaches in 48 patients with relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation.
Bone marrow transplantation 1997;20(12):1045-55.
1997: Beelen D W; Ottinger H D; Elmaagacli A; Scheulen B; Basu O; Kremens B; Havers W; Grosse-Wilde H; Schaefer U W
Transplantation of filgrastim-mobilized peripheral blood stem cells from HLA-identical sibling or alternative family donors in patients with hematologic malignancies: a prospective comparison on clinical outcome, immune reconstitution, and hematopoietic chimerism.
Blood 1997;90(12):4725-35.
1996: Scheulen B; John-Mikolajewski V; Becks H W; Beelen D W; Schaefer U W
[Rare differential diagnosis of free intra-abdominal air. Pneumatosis cystoides intestinalis]
Der Internist 1996;37(12):1260-4.
1996: Ottinger H D; Beelen D W; Scheulen B; Schaefer U W; Grosse-Wilde H
Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow.
Blood 1996;88(7):2775-9.
1996: Elmaagacli A H; Beelen D W; Becks H W; Mobascher A; Stockova J; Trzensky S; Opalka B; Schaefer U W
Molecular studies of chimerism and minimal residual disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation.
Bone marrow transplantation 1996;18(2):397-403.
1996: Ottinger H; Beelen D; Sayer H; Schaefer U W; Grosse-Wilde H
Bone marrow transplantation from partially HLA-matched related donors in adults with leukaemia: the experience at the University Hospital of Essen, Germany.
British journal of haematology 1996;92(4):913-21.
1995: Elmaagacli A H; Becks H W; Beelen D W; Stockova J; Bützler R; Opalka B; Schaefer U W
Detection of minimal residual disease and persistence of host-type hematopoiesis: a study in 28 patients after sex-mismatched, non-T cell-depleted allogeneic bone marrow transplantation for Philadelphia-chromosome positive chronic myelogenous leukemia.
Bone marrow transplantation 1995;16(6):823-9.
1995: Beelen D W; Graeven U; Elmaagacli A H; Niederle N; Kloke O; Opalka B; Schaefer U W
Prolonged administration of interferon-alpha in patients with chronic-phase Philadelphia chromosome-positive chronic myelogenous leukemia before allogeneic bone marrow transplantation may adversely affect transplant outcome.
Blood 1995;85(10):2981-90.
1994: Liedtke W; Quabeck K; Beelen D W; Straeten V; Schaefer U W
Recurrent acute inflammatory demyelinating polyradiculitis after allogeneic bone marrow transplantation.
Journal of the neurological sciences 1994;125(1):110-1.
1994: Diekmann L; Beelen D W; Quabeck K; Becher R; Schulte Holthausen H; Bützler R; Schaefer U W; Opalka B
Presence of re-appearance of BCR-ABL-positive cells years after allogeneic bone marrow transplantation for chronic-phase chronic myelogenous leukemia in patients in hematological remission.
Acta haematologica 1994;92(4):169-75.
1993: Beelen D W; Sayer H G; Franke M; Scheulen M E; Quabeck K; Mohnke M; Oidtmann M; Schaefer U W
Constant intravenous pentoxifylline infusions in allogeneic marrow transplant recipients: results of a dose escalation study.
Bone marrow transplantation 1993;12(4):363-70.
1993: Bautista Juanes J A; Theischen M; Beelen D W; Pauleikhoff D; Koch J M; Waubke T N; Wessing A
[Ocular complications of long-term survival of bone marrow transplantation. A prospective study with 21 patients]
Klinische Monatsblätter für Augenheilkunde 1993;202(2):110-5.
1992: Beelen D W; Haralambie E; Brandt H; Linzenmeier G; Müller K D; Quabeck K; Sayer H G; Graeven U; Mahmoud H K; Schaefer U W
Evidence that sustained growth suppression of intestinal anaerobic bacteria reduces the risk of acute graft-versus-host disease after sibling marrow transplantation.
Blood 1992;80(10):2668-76.
1992: Quabeck K; Müller K D; Beelen D W; Dermoumi H; Kölbel M; Kraft J; Ansorg R; Schaefer U W
Prophylaxis and treatment of fungal infections with fluconazole in bone marrow transplant patients.
Mycoses 1992;35(9-10):221-4.
1992: Steinberg F; Rehn B; Kraus R; Quabeck K; Bruch J; Beelen D W; Schaefer U W; Streffer C
Activity testing of alveolar macrophages and changes in surfactant phospholipids after irradiation in bronchoalveolar lavage: experimental and clinical data.
Environmental health perspectives 1992;97():171-5.
1991: Müller R D; Quabeck K; Beelen D W; Löhr E; Schaefer U W
[Roentgen diagnosis of pulmonary complications following allogeneic bone marrow transplantation--application of and experience with digital luminescence radiography]
Pneumologie (Stuttgart, Germany) 1991;45(12):977-86.
1991: Beelen D W; Quabeck K; Mahmoud H K; Sayer H G; Kraft J; Graeven U; Grosse-Wilde H; Quast U; Schaefer U W
[Maintenance of remission in acute myeloid leukemia by allogeneic or autologous bone marrow transplantation]
Deutsche medizinische Wochenschrift (1946) 1991;116(11):401-10.
1991: Beelen D W; Schilcher R B; Ehrlich R; Quabeck K; Schmidt U; Szy D; Grosse-Wilde H; Becher R; Schaefer U W
High-dose 1,2,4-triglycidylurazol given in regimens preparatory to bone marrow transplantation. A preclinical pharmacology study.
Cancer chemotherapy and pharmacology 1991;27(5):361-6.
1991: Beelen D W; Grosse-Wilde H; Ryschka U; Quabeck K; Sayer H G; Graeven U; Schaefer U W
Initial treatment of acute graft-versus-host disease with a murine monoclonal antibody directed to the human alpha/beta T cell receptor.
Cancer immunology, immunotherapy : CII 1991;34(2):97-102.
1990: Beelen D W; Quabeck K; Kaiser B; Wiefelspütz J; Scheulen M E; Graeven U; Grosse-Wilde H; Sayer H G; Schaefer U W
Six weeks of continuous intravenous cyclosporine and short-course methotrexate as prophylaxis for acute graft-versus-host disease after allogeneic bone marrow transplantation.
Transplantation 1990;50(3):421-7.
1990: Doxiadis I; Doxiadis G; Beelen D W; Frenz G; Schaefer U W; Vögeler U; Grosse-Wilde H
Complotyping and subtyping of MHC class I gene products in haplotype determination for bone marrow transplantation.
Haematology and blood transfusion 1990;33():709-11.
1990: Beelen D W; Quabeck K; Graeven U; Sayer H G; Schaefer U W
Influence of treatment modality, patient/donor characteristics, and disease stage on the risk of relapse after allogeneic marrow transplantation for acute leukemia.
Haematology and blood transfusion 1990;33():688-91.
1990: Schaefer U W; Beelen D W; Graeven U; Kölbel M; Sayer H; Quabeck K; Becher R; Kremens B; Stollmann B; Grosse-Wilde H
Allogeneic and autologous bone marrow transplantation in acute leukemia: the Essen Experience.
Haematology and blood transfusion 1990;33():649-51.
1990: Neuser J; Grigelat G; Quabeck K; Beelen D W; Schaefer U W
Principles of supportive psychological care for patients undergoing bone marrow transplantation.
Haematology and blood transfusion 1990;33():583-6.
1990: Molls M; Quast U; Schaefer U W; Szy D; Beelen D W; Quabeck K; Graeven U; Sayer H G; Bamberg M; Sack H
Clinical results and the Essen concept of TBI.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1990;18 Suppl 1():121-4.
1990: Quabeck K; Müller K D; Beelen D W; Dermoumi H; Kölbel M; Kraft J; Schaefer U W
[Prophylaxis and therapy of fungal infections with fluconazole in patients after bone marrow transplantation]
Mycoses 1990;33 Suppl 1():19-26.
1990: Henneberg-Quester K B; Luboldt W; Schaefer U W; Beelen D W; Quabeck K
[Erythrocyte substitution and isoagglutinin titer following ABO-incompatible bone marrow transplantation]
Beiträge zur Infusionstherapie = Contributions to infusion therapy 1990;26():200-4.
1990: Luboldt W; Henneberg-Quester K B; Schaefer U W; Beelen D W; Quabeck K; Thraenhart O
[Experiences with transfusion of CMV tested blood preparations after bone marrow transplantation]
Beiträge zur Infusionstherapie = Contributions to infusion therapy 1990;26():190-3.
1989: Westhoff U; Doxiadis I; Beelen D W; Schaefer U W; Grosse-Wilde H
Soluble HLA class I concentrations and GVHD after allogeneic marrow transplantation.
Transplantation 1989;48(5):891-3.
1989: Beelen D W; Quabeck K; Graeven U; Sayer H G; Mahmoud H K; Schaefer U W
Acute toxicity and first clinical results of intensive postinduction therapy using a modified busulfan and cyclophosphamide regimen with autologous bone marrow rescue in first remission of acute myeloid leukemia.
Blood 1989;74(5):1507-16.
1988: Quabeck K; Beelen D W; Mahmoud H K; Sayer H G; Graeven U; Schaefer U W; Schmidt C G; Hossfeld D K
Bone marrow transplantation for myeloblastoma.
European journal of haematology 1988;41(2):186-8.
1988: Beelen D W; Graeven U; Schulz G; Grosse-Wilde H; Doxiadis I; Schaefer U W; Quabeck K; Sayer H; Schmidt C G
Treatment of acute graft-versus-host disease after HLA-partially matched marrow transplantation with a monoclonal antibody (BMA031) against the T cell receptor. First results of a phase-I/II trial.
Onkologie 1988;11(1):56-8.
1987: Beelen D W; Quabeck K; Mahmoud H K; Schaefer U W; Becher R; Schmidt C G; Bamberg M; Quast U; Grosse-Wilde H; Haralambie E
Allogeneic bone marrow transplantation for acute leukaemia or chronic myeloid leukaemia in the fifth decade of life.
European journal of cancer & clinical oncology 1987;23(11):1665-71.
1987: Becher R; Beelen D W; Graeven U; Schaefer U; Schmidt C G
Triple chimaerism after allogeneic bone marrow transplantation for Philadelphia chromosome positive chronic granulocytic leukaemia.
British journal of haematology 1987;67(3):373-4.
1987: Beelen D W; Quabeck K; Mahmoud H K; Grosse-Wilde H; Shaefer U W; Schmidt C G
Influence of underlying disease and donor sex on the incidence of graft-versus-host disease in allogeneic bone marrow transplantation.
British journal of haematology 1987;65(3):385-6.
1987: Quabeck K; Beelen D W; Mahmoud H K; Schaefer U W; Schmidt C G; Henneberg-Quester K B; Luboldt W
[ABO incompatibility in allogeneic bone marrow transplantation]
Beiträge zu Infusionstherapie und klinische Ernährung 1987;18():310-5.
1987: Beelen D W; Mahmoud H K; Mlynek M L; Schmidt U; Richter H J; Schaefer U W; Reinhardt V; Pauleikhoff D
Toxoplasmosis after bone marrow transplantation.
Haematology and blood transfusion 1987;30():574-8.
1987: Grosse-Wilde H; Doxiadis I; Vögeler U; Mahmoud H K; Schäfer U W; Beelen D W; Ploegh H L
An HLA lost mutation may lead to leukemic relapse of recipient type six years after bone marrow transplantation.
Haematology and blood transfusion 1987;30():571-3.
1987: Schaefer U W; Beelen D W; Mahmoud H K; Quabeck K; Becher R; Schmidt C G; Bamberg M; Quast U; Haralambie E; Linzenmeier G
Bone marrow transplantation in acute leukemia.
Haematology and blood transfusion 1987;30():213-6.
1987: Mahmoud H K; Beelen D W; Neumann M C; Thraenhart O; Quabeck K; Schaefer U W
Cytomegalovirus hyperimmunoglobulin and substitution with blood products from antibody-negative donors. A pilot study in bone marrow transplant recipients.
Haematology and blood transfusion 1987;30():538-40.
1986: Beelen D W; Mahmoud H K; Mlynek M L; Schmidt U; Richter H J; Schaefer U W
[Toxoplasmosis after bone marrow transplantation]
Immunität und Infektion 1986;14(5):183-7.
1986: Niederle N; Kloke O; Doberauer C; Becher R; Beelen D W; Schmidt C G
[alpha 2-interferon: preliminary treatment results in chronic myeloid leukemia]
Deutsche medizinische Wochenschrift (1946) 1986;111(20):767-72.
1986: Bamberg M; Beelen D W; Mahmoud H K; Molls M; Schaefer U W
The incidence of interstitial pneumonitis: comparison of total body irradiation schedules for allogenic bone marrow transplantation.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1986;162(4):218-22.
1986: Schaefer U W; Mahmoud H K; Beelen D W; Hoffmann W; Becher R; Schmidt C G; Bamberg M; Quast U; Haralambie E; Linzenmeier G
Bone marrow transplantation in severe aplastic anemia and acute or chronic leukemia.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1986;162(4):214-7.
1986: Luboldt W; Henneberg-Quester K B; Schaefer U W; Beelen D; Mahmoud H K; Schmidt C G
[Experiences in thrombocyte substitution following bone marrow transplantation]
Beiträge zu Infusionstherapie und klinische Ernährung 1986;15():165-71.
1985: Mahmoud H K; Beelen D; Schaefer U W; Schmidt C G
[Complication-free pregnancy following bone marrow transplantation for severe aplastic anemia]
Geburtshilfe und Frauenheilkunde 1985;45(10):735-6.
1985: Beelen D W; Neumann M C; Mahmoud H K; Henneberg K; Thraenhart O; Schaefer U W
[Cytomegalovirus hyperimmune globulin and cytomegalovirus-tested blood products--a pilot study in bone marrow graft recipients]
Immunität und Infektion 1985;13(5):229-32.
1985: Mahmoud H K; Schaefer U W; Schüning F; Beelen D; Becher R; Schmidt C G; Alberti W; Haralambie E; Linzenmeier G; Stollmann B
Bone marrow transplantation for chronic granulocytic leukaemia.
Klinische Wochenschrift 1985;63(12):560-4.
1985: Mahmoud H K; Ohl S; Schaefer U W; Beelen D; Grosse-Wilde H; Doxiadis I; Richter H J; Schmidt C G
Treatment of hairy-cell leukemia with recombinant leukocyte A interferon.
Onkologie 1985;8(3):141-2.

Sign-in to see more